Results 11 to 20 of about 4,593,278 (410)

Neoadjuvant therapy

open access: yesJournal of the Chinese Medical Association, 2023
Peng-Hui, Wang   +2 more
openaire   +3 more sources

Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer. [PDF]

open access: yesMedicina (Kaunas)
Background/Objectives: The study aimed to compare the treatment effectiveness of patients with locally advanced rectal cancer undergoing standard neoadjuvant therapy or total neoadjuvant therapy.
Bayramgil A   +11 more
europepmc   +2 more sources

Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and ...
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
doaj   +1 more source

Neoadjuvant therapy in patients with locally advanced colon cancer [PDF]

open access: yesWaike lilun yu shijian, 2022
It is still unclear about neoadjuvant therapy in patients with locally advanced colon cancer (LACC). This review summarized neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted therapy and combined radio-chemotherapy for the patients
XU Zifeng, ZONG Yaping, LU Aiguo
doaj   +1 more source

Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer. [PDF]

open access: yesCancer Immunol Immunother
Objective Hypopharyngeal squamous cell carcinoma (HSCC) is a highly malignant tumor type in the head and neck region. In recent years, neoadjuvant therapy has significantly improved the laryngeal preservation rate among patients.
Yin G   +5 more
europepmc   +2 more sources

Neoadjuvant therapy for gallbladder cancer: current status and challenge [PDF]

open access: yesWaike lilun yu shijian, 2023
Gallbladder cancer is one of highly malignant digestive system tumors with insidious symptoms, rapid progression, and poor prognosis. Although radical resective surgery is the only possible curative way for gallbladder cancer, most patients have lost the
XING Ying, CHENG Shi
doaj   +1 more source

Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer

open access: yesNature Communications, 2023
Immune checkpoint inhibitors and antiangiogenic agents have shown some activity in patients with late-stage gastric cancer. Here the authors report the results of a phase II trial of neoadjuvant anti-PD1 (camrelizumab), antiangiogenic agent (apatinib ...
Song Li   +22 more
semanticscholar   +1 more source

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

open access: yesNature Network Boston, 2023
Analysis of the phase 3 CheckMate 816 trial shows that the depth of pathologic response as assessed by percent residual viable tumor is correlated with event-free survival following neoadjuvant immunotherapy plus chemotherapy, supporting pathologic ...
J. Deutsch   +23 more
semanticscholar   +1 more source

Total neoadjuvant therapy for rectal cancer: a guide for surgeons

open access: yesCanadian journal of surgery. Journal canadien de chirurgie, 2023
Summary The modern management of rectal cancers continues to evolve. With the release of data from new landmark randomized controlled trials (RAPIDO, PRODIGE-23), total neoadjuvant therapy (TNT) has moved to the forefront of locally advanced rectal ...
Garrett Johnson   +5 more
semanticscholar   +1 more source

Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients

open access: yesIndian Journal of Pathology and Microbiology, 2023
Background: The efficacy of neoadjuvant therapy for rectal cancer has not been assessed. Objective: To evaluate proportional changes in peripheral blood immune cells in rectal cancer patients after neoadjuvant therapy and assess the relationship between ...
Liu Maoxi, Liu Haiyi
doaj   +1 more source

Home - About - Disclaimer - Privacy